;

Ablatus Therapeutics achieves ISO 13485:2016 certification

15/01/2020

Ablatus has been certified to ISO 13485:2016 following successful audits with BSI.

ISO 13485 is a global standard in quality management systems for medical devices that supports polices and processes across the entire business.

CEO David Brooks said: “As we continue development of our technology for clinical use, conforming to the ISO 13485 standard is a key step to achieving this which will ultimately benefit patients world-wide. Our certification further strengthens our credibility with potential customers and partnerships”

This certification demonstrates our commitment to customer needs and patient safety, as well as allowing systems to be in place that will enable successful navigation of increasing demands from clinical best practice and regulations.

 

Article sourced from: https://ablatus.co.uk/news/ablatus-therapeutics-achieves-iso-134852016-certification/ 
Published on: 14.01.2020

Contact us

BABRAHAM RESEARCH
CAMPUS

(+44) 1223 496 000
info@babraham.co.uk

Babraham Bioscience Technologies Ltd
Babraham Research Campus
Cambridge
CB22 3AT, United Kingdom

Press Enquiries

Limewash
01223 813 557
info@limewash.co.uk

Subscribe to our mailing list

Please enter your first name
Please enter your surname
Please enter your email address
Submit
; ;